A Sponsor’s Guide to Navigating the EU Joint Clinical Assessment Framework
Prioritising Patient-Driven Outcomes for Rare Disease Biotechs The Joint Clinical Assessment (JCA) framework, established under the EU Health Technology[…]
Prioritising Patient-Driven Outcomes for Rare Disease Biotechs The Joint Clinical Assessment (JCA) framework, established under the EU Health Technology[…]